Immunocore Holdings Statistics

Total Valuation

IMCR has a market cap or net worth of $2.67 billion. The enterprise value is $2.21 billion.

Market Cap	2.67B
Enterprise Value	2.21B

Important Dates

The last earnings date was Wednesday, May 8, 2024, before market open.

Earnings Date	May 8, 2024
Ex-Dividend Date	n/a

Share Statistics

IMCR has 50.01 million shares outstanding.

Shares Outstanding	50.01M
Owned by Insiders (%)	9.62%
Owned by Institutions (%)	80.94%
Float	32.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.09
Forward PS	10.12
PB Ratio	5.84
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.96, with a Debt / Equity ratio of 1.31.

Current Ratio	5.96
Quick Ratio	5.73
Debt / Equity	1.31
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.90

Financial Efficiency

Return on equity (ROE) is -16.40% and return on invested capital (ROIC) is -7.74%.

Return on Equity (ROE)	-16.40%
Return on Assets (ROA)	-8.60%
Return on Capital (ROIC)	-7.74%
Revenue Per Employee	$531,698
Profits Per Employee	-$118,414
Employee Count	497
Asset Turnover	0.39
Inventory Turnover	0.40

Taxes

Income Tax	-7.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.26% in the last 52 weeks. The beta is 0.89, so IMCR's price volatility has been lower than the market average.

Beta (1Y)	0.89
52-Week Price Change	-5.26%
50-Day Moving Average	59.52
200-Day Moving Average	59.15
Relative Strength Index (RSI)	31.20
Average Volume (30 Days)	433,303

Short Selling Information

Short Interest	4.57M
Short Previous Month	4.09M
Short % of Shares Out	9.32%
Short % of Float	n/a
Short Ratio (days to cover)	10.64

Income Statement

In the last 12 months, IMCR had revenue of $264.25 million and -$58.85 million in losses. Loss per share was -$1.52.

Revenue	264.25M
Gross Profit	334.39M
Operating Income	-81.83M
Pretax Income	-81.81M
Net Income	-58.85M
EBITDA	-65.54M
EBIT	-72.62M
Loss Per Share	-$1.52

Full Income Statement

Balance Sheet

The company has $1.06 billion in cash and $600.66 million in debt, giving a net cash position of $457.44 million or $9.15 per share.

Cash & Cash Equivalents	1.06B
Total Debt	600.66M
Net Cash	457.44M
Net Cash Per Share	$9.15
Equity / Book Value	456.79M
Book Value Per Share	9.13
Working Capital	979.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$607,616 and capital expenditures -$3.52 million, giving a free cash flow of -$4.12 million.

Operating Cash Flow	-607,616
Capital Expenditures	-3.52M
Free Cash Flow	-4.12M
FCF Per Share	-$0.08

Full Cash Flow Statement

Margins

Gross margin is 126.54%, with operating and profit margins of -30.97% and -22.27%.

Gross Margin	126.54%
Operating Margin	-30.97%
Pretax Margin	-30.96%
Profit Margin	-22.27%
EBITDA Margin	-24.80%
EBIT Margin	-27.48%
FCF Margin	-1.56%

Dividends & Yields

IMCR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.51%
Shareholder Yield	-3.51%
Earnings Yield	-2.21%
FCF Yield	-0.15%

Dividend Details

Analyst Forecast

The average price target for IMCR is $82.77, which is 55.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$82.77
Price Target Difference	55.32%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	18.63%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IMCR has an Altman Z-Score of 1.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.85
Piotroski F-Score	3